340 related articles for article (PubMed ID: 16983087)
1. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.
Bisping E; Ikeda S; Kong SW; Tarnavski O; Bodyak N; McMullen JR; Rajagopal S; Son JK; Ma Q; Springer Z; Kang PM; Izumo S; Pu WT
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14471-6. PubMed ID: 16983087
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
[TBL] [Abstract][Full Text] [Related]
4. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
[TBL] [Abstract][Full Text] [Related]
5. Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway.
Sun S; Kee HJ; Jin L; Ryu Y; Choi SY; Kim GR; Jeong MH
J Cell Mol Med; 2018 Dec; 22(12):5964-5977. PubMed ID: 30256522
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overload.
Hamad EA; Zhu W; Chan TO; Myers V; Gao E; Li X; Zhang J; Song J; Zhang XQ; Cheung JY; Koch W; Feldman AM
PLoS One; 2012; 7(7):e39919. PubMed ID: 22792196
[TBL] [Abstract][Full Text] [Related]
7. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4.
Song R; Lei H; Feng L; Cheng W; Li Y; Yao LL; Liu J
J Biol Chem; 2021 Oct; 297(4):101189. PubMed ID: 34517007
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4.
Kwon DH; Eom GH; Kee HJ; Nam YS; Cho YK; Kim DK; Koo JY; Kim HS; Nam KI; Kim KK; Lee IK; Park SB; Choi HS; Kook H
J Mol Cell Cardiol; 2013 Dec; 65():88-97. PubMed ID: 24083978
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart.
Heineke J; Auger-Messier M; Xu J; Oka T; Sargent MA; York A; Klevitsky R; Vaikunth S; Duncan SA; Aronow BJ; Robbins J; Crombleholme TM; Molkentin JD
J Clin Invest; 2007 Nov; 117(11):3198-210. PubMed ID: 17975667
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
Oka T; Maillet M; Watt AJ; Schwartz RJ; Aronow BJ; Duncan SA; Molkentin JD
Circ Res; 2006 Mar; 98(6):837-45. PubMed ID: 16514068
[TBL] [Abstract][Full Text] [Related]
11. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.
Liu Y; Yu M; Wu L; Chin MT
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2082-92. PubMed ID: 20382855
[TBL] [Abstract][Full Text] [Related]
12. Induction of cardiomyocyte proliferation and angiogenesis protects neonatal mice from pressure overload-associated maladaptation.
Malek Mohammadi M; Abouissa A; Azizah I; Xie Y; Cordero J; Shirvani A; Gigina A; Engelhardt M; Trogisch FA; Geffers R; Dobreva G; Bauersachs J; Heineke J
JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335322
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.
Fisch S; Gray S; Heymans S; Haldar SM; Wang B; Pfister O; Cui L; Kumar A; Lin Z; Sen-Banerjee S; Das H; Petersen CA; Mende U; Burleigh BA; Zhu Y; Pinto YM; Liao R; Jain MK
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7074-9. PubMed ID: 17438289
[TBL] [Abstract][Full Text] [Related]
14. The Action and Mechanism of Trehalose on GATA4 Autophagy Degradation and Ventricular Remodeling.
Chai Q; Zhang W; Gao L; Yang Y; Miao M; Liu D; Chen L; Zheng M; Xin S
Discov Med; 2023 Jun; 35(176):394-404. PubMed ID: 37272106
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
16. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
[TBL] [Abstract][Full Text] [Related]
17. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
Bisping E; Ikeda S; Sedej M; Wakula P; McMullen JR; Tarnavski O; Sedej S; Izumo S; Pu WT; Pieske B
J Biol Chem; 2012 Mar; 287(13):9827-9834. PubMed ID: 22228770
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D2 rescues size and function of GATA4 haplo-insufficient hearts.
Yamak A; Temsah R; Maharsy W; Caron S; Paradis P; Aries A; Nemer M
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1057-66. PubMed ID: 22923619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
